The article from the early phase clinical feasibility study with RESPINOR DXT (WEAN-US study) have been published in Critical Care.

We are delighted to share these results that confirmed proof of principle and proof of concept for RESPINOR DXT.

Conclusion: 

"The Operator-independent CUSdi quantifies diaphragm excursion and peak velocity similar to standard ultrasound and can reliably predict weaning failure with a defined cut-off value of 1.1 cm, which is consistent with the literature. The technology has a good safety profile as no adverse device effects have been reported. First, it allows the measurement of ultrasound derived indices of diaphragm motion by operators that are not trained for diaphragm ultrasound. Second, these measures can be performed continuously and repeatedly."

https://ccforum.biomedcentral.com

‍

‍

‍

‍

‍

‍